Drug profile · INN
botulinum toxin type a
BOTOX
botulinum toxin type a (BOTOX) is a synaptosomal nerve-associated protein 25 (snap-25) hydrolytic enzyme. Associated with AbbVie.
EMA: approved TGA: approved PMDA: approved Musculo-skeletal system (M03) M03AX01
Patents linked 0
Pipeline programs 16
News articles 0
Drug details — botulinum toxin type a
- Class
- Musculo-skeletal system (M03)
- Route
- —
- Patents
- 0
- Programs
- 16
- Data quality
- 0.83
Quick answer
botulinum toxin type a (BOTOX) is a synaptosomal nerve-associated protein 25 (snap-25) hydrolytic enzyme. Associated with AbbVie.
Key facts
INN botulinum toxin type a
Brand BOTOX
Mechanism Synaptosomal nerve-associated protein 25 (SNAP-25) hydrolytic enzyme
Target Synaptosomal-associated protein 25
Therapeutic class Musculo-skeletal system (M03)
ATC code M03AX01
Originator AbbVie
Mechanism of action
Synaptosomal nerve-associated protein 25 (SNAP-25) hydrolytic enzyme
Primary target: Synaptosomal-associated protein 25
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
| TGA | approved | — |
| PMDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is botulinum toxin type a?
botulinum toxin type a (BOTOX) is a synaptosomal nerve-associated protein 25 (snap-25) hydrolytic enzyme. Associated with AbbVie.
What is the brand name for botulinum toxin type a?
BOTOX is a marketed brand name for botulinum toxin type a. Check FDA Drugs@FDA for the current US label holder and prescribing information.